This article is more than 5 years old. Information may no longer be current.
Around 1,500 MERS cases, 500 deaths averted since 2016
Click Here to Manage Email Alerts
Researchers estimated that nearly 1,500 cases of Middle East respiratory syndrome coronavirus, or MERS-CoV, and around 500 related deaths may have been averted since 2016 through global efforts to detect infections and reduce transmission.
“We have noticed a decline in case detections since 2016 and suspected that this was due to efforts in countries to reduce human-to-human transmission in hospitals. This study is our attempt to quantify the investment in prevention and response efforts in terms of cases and deaths averted,” Maria D. Van Kerkhove, PhD, an infectious disease epidemiologist and MERS-CoV technical lead with WHO, told Infectious Disease News.
“Often, we tell the story of how an outbreak was brought under control after the outbreak is detected. What we are attempting here is to show that we can prevent outbreaks from occurring through the prevention of infections — either through camel-to-human transmission or from human-to-human transmission.”
Van Kerhove and colleagues analyzed data reported to WHO to estimate the potential number of MERS cases and deaths that may have been averted since 2016 had the risk levels of 2014-2015 continued.
As Van Kerhove explained, they used information about where each patient was infected — for example, through contact with a camel or nosocomial transmission — and compared the incidence of case reports before and after 2016. From this, Van Kerkhove said the team estimated how many cases would have occurred if the incidence was what it was before 2016 to the number of cases reported in 2017 and 2018, with assistance from colleagues at the University of Oxford, Imperial College London and the Pasteur Institute.
Data collection showed that, of the 2,254 laboratory-confirmed cases reported to WHO from 2012 through Oct. 1, 2018, 1,087 were a result of human-to-human transmission and 1,167 were classified as community-acquired cases. After 739 cases were reported in 2014 and 768 cases in 2015, only 244 cases were reported in 2016, 244 in 2017, and 113 in 2018 through September, according to Van Kerhove and colleagues.
Community-acquired cases numbered 177 in 2016, 151 in 2017, and 86 through September 2018, the researchers found. According to the report, these rates were each significantly (P < .001) lower than expected compared with the incidence in 2014-2015. Van Kerhove and colleagues said they observed no significant reduction in the risk for secondary cases from 2014-2015 to 2016, 2017, and through September 2018.
Based on their findings, the researchers estimated the total number of cases averted at 507 (95% CI, 189–967) in 2016, 507 (95% CI, 189–967) in 2017, and 451 (95% CI, 191–855) through September 2018, totaling 1,465 cases. Assuming a 35.5% case-fatality ratio, this corresponds to an estimated 520 (95% CI, 318–769) expected deaths averted, they said.
According to Van Kerkhove, the reduction in cases is due to a combination of efforts to reduce the risk for infection — including improvements in early detection in affected countries and enhancements in surveillance of human and camel populations — and to contain outbreaks when they occur.
“We need to do more to prevent cases and deaths. MERS-CoV is a high-threat respiratory pathogen with the potential to cause large-scale outbreaks with significant morbidity and mortality, health security and financial impacts,” Van Kerhove said.
“Each case has the opportunity to seed an outbreak, and we need political involvement to support the ministries of health and ministries of agriculture to tackle MERS at its source. Each individual case that is saved is significant, and the work of the ministries of health and each of our public health and academic partners across the globe should be commended and encouraged to do more.” – by Caitlyn Stulpin
Disclosures: The authors report no relevant financial disclosures.
Click Here to Manage Email Alerts